Re:Goldman Sachs questions whether curing patients is a sust...
by PeterStuer on Friday April 13, 2018 @08:33AM
(#16829344)
As far as I remember flu vaccines work by looking at the origins of the yearly epidemic (in the east, typically china etc.), predicting which strains will become the dominant ones and then starting to cultivate neutered forms of those (in eggs) on a mass scale to have the vaccines ready by the time the epidemic hits 'the west'. Some years the predictions of the strain are wrong and the vaccines less useful as most people will get another strain.
[ Parent
| on HN ]
Re:Goldman Sachs questions whether curing patients is a sust...
by kdelok on Friday April 13, 2018 @06:01PM
(#16834265)
They do strain selection twice a year (once for northern, once for southern hemisphere). The years where they get it wrong are usually the years where the strain jumps between different clusters.
It's really interesting stuff. Take a look at https://www.whocc.infectiousdisease.cam.ac.uk/antigenic-cart... for a bit of an overview on that stuff.